Cargando…
Network pharmacology and molecular docking study on the active ingredients of qidengmingmu capsule for the treatment of diabetic retinopathy
Diabetic retinopathy (DR) is a leading cause of irreversible blindness globally. Qidengmingmu Capsule (QC) is a Chinese patent medicine used to treat DR, but the molecular mechanism of the treatment remains unknown. In this study, we identified and validated potential molecular mechanisms involved i...
Autores principales: | Zhang, Mingxu, Yang, Jiawei, Zhao, Xiulan, Zhao, Ying, Zhu, Siquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016862/ https://www.ncbi.nlm.nih.gov/pubmed/33795817 http://dx.doi.org/10.1038/s41598-021-86914-8 |
Ejemplares similares
-
Author Correction: Network pharmacology and molecular docking study on the active ingredients of qidengmingmu capsule for the treatment of diabetic retinopathy
por: Zhang, Mingxu, et al.
Publicado: (2021) -
Integrating network pharmacological and experimental models to investigate the therapeutic effects of baicalein in glaucoma
por: Yang, Jiawei, et al.
Publicado: (2021) -
Exploring the active ingredients and mechanism of Shenzhi Tongxin capsule against microvascular angina based on network pharmacology and molecular docking
por: Xuan, Xiaoyu, et al.
Publicado: (2023) -
Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy
por: Yao, Hongyan, et al.
Publicado: (2021) -
Exploring the Active Ingredients and Mechanism of Action of Huanglian Huazhuo Capsule for the Treatment of Obese Type-2 Diabetes Mellitus Based on Using Network Pharmacology and Molecular Docking
por: Wang, Na, et al.
Publicado: (2022)